Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) had its target price increased by investment analysts at Barclays from $37.00 to $41.00 in a research report issued on Friday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price target would indicate a potential upside of 12.70% from the stock’s current price.
A number of other research analysts have also recently commented on the stock. Citigroup raised shares of Keurig Dr Pepper from a “neutral” rating to a “buy” rating and upped their target price for the company from $36.00 to $43.00 in a research report on Monday, September 23rd. BNP Paribas started coverage on shares of Keurig Dr Pepper in a research report on Monday, June 24th. They issued a “neutral” rating and a $36.00 target price on the stock. TD Cowen upped their target price on shares of Keurig Dr Pepper from $35.00 to $40.00 and gave the company a “hold” rating in a research report on Thursday, September 26th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Keurig Dr Pepper from $36.00 to $37.00 and gave the company a “hold” rating in a research report on Monday, September 23rd. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $41.00 target price on shares of Keurig Dr Pepper in a research report on Friday, July 26th. Seven analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, Keurig Dr Pepper has an average rating of “Moderate Buy” and an average price target of $37.86.
Read Our Latest Analysis on KDP
Keurig Dr Pepper Trading Down 0.4 %
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last announced its quarterly earnings results on Thursday, July 25th. The company reported $0.45 earnings per share for the quarter, meeting the consensus estimate of $0.45. The firm had revenue of $3.92 billion for the quarter, compared to analysts’ expectations of $3.91 billion. Keurig Dr Pepper had a net margin of 14.47% and a return on equity of 10.32%. The company’s revenue was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.42 EPS. As a group, equities analysts predict that Keurig Dr Pepper will post 1.92 earnings per share for the current year.
Institutional Trading of Keurig Dr Pepper
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. CX Institutional raised its holdings in Keurig Dr Pepper by 3.6% during the third quarter. CX Institutional now owns 8,129 shares of the company’s stock worth $305,000 after purchasing an additional 283 shares in the last quarter. Farmers & Merchants Investments Inc. grew its position in shares of Keurig Dr Pepper by 51.5% during the second quarter. Farmers & Merchants Investments Inc. now owns 886 shares of the company’s stock worth $30,000 after acquiring an additional 301 shares during the last quarter. Federated Hermes Inc. grew its position in shares of Keurig Dr Pepper by 21.8% during the second quarter. Federated Hermes Inc. now owns 1,757 shares of the company’s stock worth $59,000 after acquiring an additional 314 shares during the last quarter. Mather Group LLC. grew its position in shares of Keurig Dr Pepper by 29.0% during the second quarter. Mather Group LLC. now owns 1,742 shares of the company’s stock worth $53,000 after acquiring an additional 392 shares during the last quarter. Finally, Hexagon Capital Partners LLC grew its position in shares of Keurig Dr Pepper by 105.6% during the third quarter. Hexagon Capital Partners LLC now owns 1,032 shares of the company’s stock worth $39,000 after acquiring an additional 530 shares during the last quarter. Institutional investors and hedge funds own 85.23% of the company’s stock.
About Keurig Dr Pepper
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Featured Articles
- Five stocks we like better than Keurig Dr Pepper
- Insider Buying Explained: What Investors Need to Know
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- What Are Growth Stocks and Investing in Them
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- Options Trading – Understanding Strike Price
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.